TB-500 (10 mg) is a fragment related to thymosin beta-4, studied for roles in actin regulation (a key part of cell structure), cell migration, and tissue remodeling, which are relevant during recovery from soft tissue stress
RUO and IUO labeling guidance for laboratory research products
April 18 Product: Genentechs Alecensa Indication: Non-small cell lung cancer The FDA approved Genentechs Alecensa Thursday as the first adjuvant treatment for patients with early-stage, anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer who have undergone tumor resection
This includes physical therapy, exercise, proper nutrition, and lifestyle modifications
What the Research on KPV Actually Shows Preclinical lab or animal research has revealed some interesting, potentially promising data on KPV